Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Libang Zhaoxin Biotechnology is the dedicated research and development subsidiary of the Xi'an Libang Pharmaceutical Group, based in Xi'an, China. The company specializes in the development of advanced drug delivery systems, with a core focus on lipid emulsion technology and complex injectable formulations. Its research efforts are primarily directed toward the therapeutic areas of anesthesia, cardiovascular medicine, and clinical nutrition. By leveraging proprietary platforms, Libang Zhaoxin creates specialized formulations that enhance the stability and safety profiles of poorly soluble drugs. The company supports the parent group's market-leading portfolio while advancing a pipeline of innovative therapeutic candidates and improved generics. Libang Zhaoxin is recognized as a key player in the Chinese high-end formulation sector, particularly for critical care medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Libang Zhaoxin Biotechnology.